Last $19.18 USD
Change Today 0.00 / 0.00%
Volume 0.0
NUTR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

nutraceutical intl corp (NUTR) Key Developments

Nutraceutical International Corporation, Annual General Meeting, Jan 26, 2015

Nutraceutical International Corporation, Annual General Meeting, Jan 26, 2015., at 09:00 US Mountain Standard Time. Location: The Grand America Hotel. Agenda: To consider the election of two class II directors, each for a term of three years; to consider the ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending September 30, 2015; to consider the advisory vote to approve named executive officer compensation; and to consider the any other business that may properly come before the meeting or any adjournment of the meeting.

Nutraceutical International Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended September 30, 2014

Nutraceutical International Corporation reported unaudited consolidated earnings results for the fourth quarter and year ended September 30, 2014. For the quarter, the company reported net sales of $52,440,000 against $51,256,000 a year ago. Income from operations was $5,688,000 against $6,988,000 a year ago. Income before provision for income taxes was $5,291,000 against $6,652,000 a year ago. Net income was $3,433,000 or $0.35 per basic and diluted share against $4,136,000 or $0.42 per basic and diluted share a year ago. Adjusted EBITDA was $9,066,000 against $9,578,000 a year ago. For the year, the company reported net sales of $214,474,000 against $208,397,000 a year ago. Income from operations was $26,497,000 against $28,133,000 a year ago. Income before provision for income taxes was $25,076,000 against $26,773,000 a year ago. Net income was $15,889,000 or $1.62 per diluted share against $17,008,000 or $1.73 per diluted share a year ago. Adjusted EBITDA was $38,232,000 against $38,048,000 a year ago. Operating cash flow for the fiscal year ended September 30, 2014 was $20.0 million compared to $26.8 million for fiscal 2013. The operating cash flow for the fiscal year ended September 30, 2014, combined with net borrowings of $10.5 million and existing cash, was primarily used to invest $16.4 million in acquisitions of natural product businesses, $11.3 million in purchases of property, plant and equipment and $5.1 million in purchases of common stock for treasury. Net sales growth of 2.9% was comparable to fiscal 2013 net sales growth of 4.0%. Fiscal 2014 growth came primarily from acquisitions completed during the last two fiscal years. Adjusted EBITDA for fiscal 2014 increased slightly despite the increased costs and internal time dedicated to recent acquisitions. The decrease in fiscal 2014 net income was primarily a result of increased amortization and depreciation expense relating to acquisitions and capital investments made to enhance future growth and reduce costs, including a substantial investment in new laboratory facilities and equipment.

Nutraceutical International Seeks Acquisitions

Nutraceutical International Corporation (NasdaqGS:NUTR) is seeking acquisitions. Bill Gay, Chairman and Chief Executive Officer, commented, "The decrease in fiscal 2014 net income was primarily a result of increased amortization and depreciation expense relating to acquisitions and capital investments made to enhance future growth and reduce costs, including a substantial investment in new laboratory facilities and equipment. These and similar investments we have made and continue to make in technology, acquisitions and expanding manufacturing capacity are important for future growth capacity and reduced operational costs."

Nutraceutical International Increases Credit Line

Nutraceutical International Corporation has closed on an amended revolving credit facility, with Rabobank International continuing as lead bank under the facility. Wells Fargo will also remain as a lender and is currently Nutraceutical's primary US commercial banking partner. This amended credit facility extends the term of the line of credit to November 2019, increases the ongoing commitment from $90 million to $100 million and provides an additional accordion feature to increase the commitment up to $130 million, subject to certain conditions.

Nutraceutical International Corporation Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2014

Nutraceutical International Corporation announced unaudited consolidated earnings results for the third quarter and nine months ended June 30, 2014. For the quarter, the company reported net sales of $55,625,000 compared to $50,814,000 a year ago. Income from operations was $6,686,000 compared to $6,427,000 a year ago. Income before provision for income taxes was $6,330,000 compared to $6,091,000 a year ago. Net income was $3,997,000 or $0.41 per basic and diluted common share compared to $3,842,000 or $0.39 per basic and diluted common share a year ago. Adjusted EBITDA was $9,628,000 compared to $8,913,000 a year ago. For the nine months, the company reported net sales of $162,034,000 compared to $157,141,000 a year ago. Income from operations was $20,809,000 compared to $21,145,000 a year ago. Income before provision for income taxes was $19,785,000 compared to $20,121,000 a year ago. Net income was $12,456,000 or $1.27 per diluted common share compared to $12,872,000 or $1.31 per diluted common share a year ago. Adjusted EBITDA was $29,166,000 compared to $28,470,000 a year ago. Operating cash flow for the nine months ended June 30, 2014 was $16.1 million compared to $19.2 million for the same period of fiscal 2013. The operating cash flow for the nine months ended June 30, 2014, combined with net borrowings of $9.0 million and existing cash, was primarily used to invest $16.2 million in acquisitions of natural product businesses, $8.6 million in purchases of property, plant and equipment and $3.8 million in purchases of common stock for treasury.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NUTR:US $19.18 USD 0.00

NUTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aceto Corp $19.57 USD -0.25
GNC Holdings Inc $45.67 USD -0.20
Nature's Sunshine Products Inc $14.50 USD -0.02
USANA Health Sciences Inc $102.29 USD +0.44
Vitamin Shoppe Inc $43.10 USD +0.09
View Industry Companies
 

Industry Analysis

NUTR

Industry Average

Valuation NUTR Industry Range
Price/Earnings 11.9x
Price/Sales 0.9x
Price/Book 1.2x
Price/Cash Flow 10.0x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NUTRACEUTICAL INTL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.